Literature DB >> 2825989

Identification of new drugs in small cell lung cancer: phase II agents first?

J Aisner1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2825989

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.

Authors:  Y Sasaki; T Shinkai; K Eguchi; T Tamura; Y Ohe; T Ohmori; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.

Authors:  M H Bronchud; M R Potter; G Morgenstern; M J Blasco; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.